Wolverine Trading, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Wolverine Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$14.68 - $16.92 $155,740 - $179,504	10,609 New	10,609 $164,000
Q4 2022 Feb 14, 2023	BUY	$12.25 - $19.5 $257,838 - $410,436	21,048 New	21,048 $391,000
Q2 2021 Aug 06, 2021	SELL	$4.29 - $6.05 $67,018 - $94,513	-15,622 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$3.45 - $4.69 $12,447 - $16,921	-3,608 Reduced 18.76%	15,622 $68,000
Q4 2020 Feb 12, 2021	BUY	$2.97 - $3.83 $57,113 - $73,650	19,230 New	19,230 $66,000
Q2 2020 Aug 13, 2020	SELL	$3.48 - $5.05 $104,838 - $152,136	-30,126 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$2.61 - $5.21 $18,494 - $36,918	7,086 Added 30.76%	30,126 $117,000
Q3 2019 Nov 14, 2019	BUY	$3.89 - $7.43 $89,625 - $171,187	23,040 New	23,040 $121,000
Q4 2018 Feb 14, 2019	SELL	$1.92 - $3.62 $59,629 - $112,426	-31,057 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.81 - $3.78 $87,270 - $117,395	31,057 New	31,057 $117,000

345

98.4M

13.4K

11.7K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.22B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.